BRIGHTON BIOTECH

Brighton Biotech ("BBI") and Augment Pharmaceuticals, Inc. ("Augment") merged in May 2015 to combine their pipelines and resources to form a new private biopharmaceutical company developing products in two indications of important unmet medical need... Specializes in acquiring and developing pharmaceutical and biotechnology products for the treatment and/or prevention of serious unmet medical needs.

Also known as: Brighton Biotech Inc.

Primary location: New York United States